EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,866,000 | +5.0% | 42,911 | +20.9% | 0.01% | 0.0% |
| Q3 2021 | $1,777,000 | -24.3% | 35,502 | -4.7% | 0.01% | -36.4% |
| Q2 2021 | $2,347,000 | -54.9% | 37,259 | -33.5% | 0.01% | -59.3% |
| Q1 2021 | $5,202,000 | -11.5% | 55,998 | -14.7% | 0.03% | -20.6% |
| Q4 2020 | $5,881,000 | +44.0% | 65,629 | +66.0% | 0.03% | +30.8% |
| Q3 2020 | $4,085,000 | +25.6% | 39,532 | -3.9% | 0.03% | +18.2% |
| Q2 2020 | $3,252,000 | +6.9% | 41,121 | -21.8% | 0.02% | -12.0% |
| Q1 2020 | $3,042,000 | +81.7% | 52,574 | +69.4% | 0.02% | +108.3% |
| Q4 2019 | $1,674,000 | -35.6% | 31,036 | -37.6% | 0.01% | -42.9% |
| Q3 2019 | $2,599,000 | +21.8% | 49,727 | +12.6% | 0.02% | +23.5% |
| Q2 2019 | $2,133,000 | +10.3% | 44,150 | +15.3% | 0.02% | 0.0% |
| Q1 2019 | $1,933,000 | – | 38,276 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |